ClinicalTrials.gov
public full text
Public Domain
Probenecid as Medication for Alcohol Use Disorder (PROB)
The design is a randomized, within-subject, crossover, double-blind, placebo-controlled human alcohol laboratory study with one oral dose of 2g probenecid or placebo administered in two laboratory sessions.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Dataset of in vitro and in vivo pharmacological studies of probenecid in benign prostatic hyperplasia#425526
- A Phase II Study to Evaluate the Efficacy and Safety of Oral Ceritinib in Patients With ALK-positive NSCLC Metastatic to the Brain and/or to Leptomeninges#839156
- Effect of Probenecid on Pexidartinib Pharmacokinetics#852619
- GDNF in ideopathicParkinsons Disease#844651
- Clofazamine for the Treatment of Mycobacterium Avium Intracellulare(MAI)#894054
Record · ID 835011
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive